Type 1 Diabetes Mellitus — Propranolol in Treating Hypoglycemia Unawareness
Citation(s)
Barnes MB, Lawson MA, Beverly JL Rate of fall in blood glucose and recurrent hypoglycemia affect glucose dynamics and noradrenergic activation in the ventromedial hypothalamus. Am J Physiol Regul Integr Comp Physiol. 2011 Dec;301(6):R1815-20. doi: 10.1152/ajpregu.00171.2011. Epub 2011 Sep 28.
Barnett AH, Leslie D, Watkins PJ Can insulin-treated diabetics be given beta-adrenergic blocking drugs? Br Med J. 1980 Apr 5;280(6219):976-8.
Chan O, Sherwin R Influence of VMH fuel sensing on hypoglycemic responses. Trends Endocrinol Metab. 2013 Dec;24(12):616-24. doi: 10.1016/j.tem.2013.08.005. Epub 2013 Sep 21. Review.
Cryer PE Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2013 Jul 25;369(4):362-72. doi: 10.1056/NEJMra1215228. Review.
Cryer PE The barrier of hypoglycemia in diabetes. Diabetes. 2008 Dec;57(12):3169-76. doi: 10.2337/db08-1084. Review.
Dagogo-Jack S, Rattarasarn C, Cryer PE Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes. 1994 Dec;43(12):1426-34.
Geddes J, Schopman JE, Zammitt NN, Frier BM Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet Med. 2008 Apr;25(4):501-4. doi: 10.1111/j.1464-5491.2008.02413.x.
Kerr D, MacDonald IA, Heller SR, Tattersall RB Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects. Br J Clin Pharmacol. 1990 Jun;29(6):685-93.
Marengo C, Marena S, Renzetti A, Mossino M, Pagano G Beta-blockers in hypertensive non-insulin-dependent diabetics: comparison between penbutolol and propranolol on metabolic control and response to insulin-induced hypoglycemia. Acta Diabetol Lat. 1988 Apr-Jun;25(2):141-8.
Odugbesan O, Toop M, Barnett AH Beta-and alpha-adrenergic blockade and metabolic responses to insulin induced hypoglycaemia in diabetics. Diabetes Res. 1987 Jul;5(3):135-8.
Ramanathan R, Cryer PE Adrenergic mediation of hypoglycemia-associated autonomic failure. Diabetes. 2011 Feb;60(2):602-6. doi: 10.2337/db10-1374.
Shorr RI, Ray WA, Daugherty JR, Griffin MR Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas. JAMA. 1997 Jul 2;278(1):40-3.
Szepietowska B, Zhu W, Chan O, Horblitt A, Dziura J, Sherwin RS Modulation of ß-adrenergic receptors in the ventromedial hypothalamus influences counterregulatory responses to hypoglycemia. Diabetes. 2011 Dec;60(12):3154-8. doi: 10.2337/db11-0432. Epub 2011 Oct 19.
Viberti GC, Keen H, Bloom SR Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in normal subjects. Metabolism. 1980 Sep;29(9):866-72.
Propranolol as a Treatment for Impaired Awareness of Hypoglycemia in Type 1 Diabetes
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
